相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
Yoon-Koo Kang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
Jina Yun et al.
EUROPEAN JOURNAL OF CANCER (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery
Susumu Hijioka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Capecitabine with radiation is an effective adjuvant therapy in gastric cancers
Chee Kian Tham et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
P. C. Enzinger et al.
ANNALS OF ONCOLOGY (2009)
Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
E. Goekkurt et al.
ANNALS OF ONCOLOGY (2009)
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
A. F. C. Okines et al.
ANNALS OF ONCOLOGY (2009)
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Y. -K. Kang et al.
ANNALS OF ONCOLOGY (2009)
Overall Survival: A Gold Standard in Search of a Surrogate The Value of Progression-Free Survival and Time to Progression as End Points of Drug Efficacy
Sen H. Zhuang et al.
CANCER JOURNAL (2009)
Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative Oncology Group, TCOG GC-0501 Trial
Wasaburo Koizumi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
Narikazu Boku et al.
LANCET ONCOLOGY (2009)
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens
Ramazan Yildiz et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2009)
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
Bhumsuk Keam et al.
BMC CANCER (2008)
Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)
Masashi Fujii
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302)
Hiroya Takiuchi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC)
Satoshi Morita et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
W Koizumi et al.
BRITISH JOURNAL OF CANCER (2003)
分享论文
